Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 337

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART)

Open access
Hayes, Richard J., Donnell, Deborah, Floyd, Sian, Mandla, Nomtha, Bwalya, Justin, Sabapathy, Kalpana, Yang, Blia, Phiri, Mwelwa, Schaap, Ab, Eshleman, Susan H., Piwowar-Manning, Estelle, Kosloff, Barry, James, Anelet, Skalland, Timothy, Wilson, Ethan, Emel, Lynda, Macleod, David, Dunbar, Rory, Simwinga, Musonda, Makola, Nozizwe, Bond, Virginia, Hoddinott, Graeme, Moore, Ayana, Griffith, Sam, Deshmane Sista, Nirupama, Vermund, Sten H., El-Sadr, Wafaa, Burns, David N., Hargreaves, James R., Hauck, Katharina, Fraser, Christophe, Shanaube, Kwame, Bock, Peter, Beyers, Nulda, Ayles, Helen, Fidler, Sarah · 2019 · New England Journal of Medicine

Abstract

BACKGROUND: A universal testing and treatment strategy is a potential approach to reduce the incidence of human immunodeficiency virus (HIV) infection, yet previous trial results are inconsistent. METHODS: In the HPTN 071 (PopART) community-randomized trial conducted from 2013 through 2018, we randomly assigned 21 communities in Zambia and South Africa (total population, approximately 1 million) to group A (combination prevention intervention with universal antiretroviral therapy [ART]), group B (the prevention intervention with ART provided according to local guidelines [universal since 2016]), or group C (standard care). The prevention intervention included home-based HIV testing delivered by community workers, who also supported linkage to HIV care and ART adherence. The primary outcome, HIV incidence between months 12 and 36, was measured in a population cohort of approximately 2000 randomly sampled adults (18 to 44 years of age) per community. Viral suppression (<400 copies of HIV RNA per milliliter) was assessed in all HIV-positive participants at 24 months. RESULTS: The population cohort included 48,301 participants. Baseline HIV prevalence was 21% or 22% in each group. Between months 12 and 36, a total of 553 new HIV infections were observed during 39,702 person-years (1.4 per 100 person-years; women, 1.7; men, 0.8). The adjusted rate ratio for group A as compared with group C was 0.93 (95% confidence interval [CI], 0.74 to 1.18; P = 0.51) and for group B as compared with group C was 0.70 (95% CI, 0.55 to 0.88; P = 0.006). The percentage of HIV-positive participants with viral suppression at 24 months was 71.9% in group A, 67.5% in group B, and 60.2% in group C. The estimated percentage of HIV-positive adults in the community who were receiving ART at 36 months was 81% in group A and 80% in group B. CONCLUSIONS: A combination prevention intervention with ART provided according to local guidelines resulted in a 30% lower incidence of HIV infection than standard care. The lack of effect with universal ART was unanticipated and not consistent with the data on viral suppression. In this trial setting, universal testing and treatment reduced the population-level incidence of HIV infection. (Funded by the National Institute of Allergy and Infectious Diseases and others; HPTN 071 [PopArt] ClinicalTrials.gov number, NCT01900977.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1814556

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 24 references

Cited by

See all 337

Metadata

Authors
Hayes, R. J., Donnell, D., Floyd, S., Mandla, N., Bwalya, J., Sabapathy, K., Yang, B., Phiri, M., Schaap, A., Eshleman, S. H., Piwowar-Manning, E., Kosloff, B., James, A., Skalland, T., Wilson, E., Emel, L., Macleod, D., Dunbar, R., Simwinga, M., Makola, N., Bond, V., Hoddinott, G., Moore, A., Griffith, S., Deshmane Sista, N., Vermund, S. H., El-Sadr, W., Burns, D. N., Hargreaves, J. R., Hauck, K., Fraser, C., Shanaube, K., Bock, P., Beyers, N., Ayles, H., & Fidler, S.
Venue
New England Journal of Medicine
Published
2019-07-18
Volume
381
Issue
3
Pages
207-218
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2961360820
Cited by
337
References
24
FWCI
36.72
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART). https://app.cochat.ai/papers/10.1056/nejmoa1814556
The paper
Hayes, R. J., Donnell, D., Floyd, S., Mandla, N., Bwalya, J., Sabapathy, K., Yang, B., Phiri, M., Schaap, A., Eshleman, S. H., Piwowar-Manning, E., Kosloff, B., James, A., Skalland, T., Wilson, E., Emel, L., Macleod, D., Dunbar, R., Simwinga, M., . . . Fidler, S. (2019). Effect of Universal Testing and Treatment on HIV Incidence — HPTN 071 (PopART). New England Journal of Medicine. https://doi.org/10.1056/nejmoa1814556

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.